AI IN REGULATORY AFFAIRS: What FDA and EU Programs Mean for the Future of Compliance

Artificial Intelligence is revolutionizing healthcare, but with innovation comes new regulatory complexity. This white paper breaks down the evolving AI regulatory landscape in the U.S. and EU, including the FDA’s AI/ML Action Plan, PCCPs, and the EU AI Act.

Learn how MedTech companies can stay compliant while developing safe, effective, and adaptive AI-driven products.

Download now to stay ahead of regulatory expectations and future-proof your AI strategy.